About this event

  • Date and time Mon 1 Nov 2021 from 8:30am to 5:00pm
  • Location Royal Society of Medicine
  • Organised by Gastroenterology and Hepatology

This meeting is an opportunity for delegates to refresh their knowledge in the management of key hepatological topics. Talks will be delivered by leading experts in their field and there will be an emphasis on recent clinical advances in these areas to allow participants to be kept fully updated. Join this meeting to understand the advances in managing complications of liver disease and more.

During this event delegates will:

  • Understand acute liver injuries in the context of patients with and without cirrhosis

  • Be informed about the management of fatty liver disease including both alcohol and non-alcohol related disease

  • Receive updates on liver cancer

  • Discover advances in the management of vascular liver disorders

This meeting is particularly relevant for general practitioners, general physicians, and specialist hepatologists.

Can't make it to London? Click here to book the live stream of this event.

We would like to thank our sponsor Shionogi UK for their support of this meeting. Please note that the sponsor has not had any influence or involvement over the agenda, content or organisation of this meeting.

Tickets

Standard pricing available until 31 October 2021.

Member

RSM Fellow RSM Associate RSM Retired Fellow RSM Trainee RSM Student
£96.00 £57.00 £57.00 £57.00 £30.00

Non - Member

Consultant / GP AHP / Nurse / Midwife Non Healthcare Professional Trainee Student
£160.00 £95.00 £95.00 £95.00 £50.00

Key speakers

Professor Mark Thursz

Head of Department, Metabolism Digestion and Reproduction, Imperial College London

Speaker's biography

Mark Thursz is professor of hepatology in the Division of Digestive Diseases and Head of the Department of Metabolism, Digestion & Reproduction in the Faculty of Medicine at Imperial College London. Professor Thursz is a clinical hepatologist with inpatient beds and a clinic at St Mary’s Hospital. He was educated at King’s College London and trained in Gastroenterology and Hepatology at St Mary’s being appointed as senior Lecturer and honorary consultant in 1997. Professor Thursz runs a translation research programmes in alcohol-related liver disease and hepatitis B virus infection. He ran the NIHR-HTA funded Steroids or Pentoxifylline for Alcoholic Hepatitis (STOPAH) trial which explored the utility of existing treatments for alcoholic hepatitis and is now involved in a portfolio of trials in alcohol-related liver disease. Recently granted an MRC Stratified Medicine award he is now exploring novel biomarkers for diagnosis, prognosis and risk of infection in this condition. He is chief investigator for the NUC-B trial (funded by NIHR-EME) and a co-investigator on the PROLIFICA Programme for hepatitis patients in Sub-Saharan Africa. Professor Thursz was Secretary-General of the European Association for Study of the Liver 2011-13. He is currently Director of the Imperial College Biomedical Research Centre and Trust Research Director for Imperial College Healthcare NHS Trust

Dr David Patch

Consultant Hepatologist, Royal Free Hospital

Speaker's biography

David Patch was appointed as consultant to the Royal Free in 2019. His interests are portal hypertension and the management of splanchnic vein thrombosis. The Royal Free team has developed a thrombolysis pathway for patients with acute portal vein thrombosis, and this has become particularly relevant in the COVID vaccine era. He is married with three grown up children  and a dog called Norman

Professor Shahid Khan

Consultant Hepatologist, Imperial College London

Speaker's biography

Professor Shahid A Khan is Professor of Practice (Hepatology) at Imperial College London and an NHS Consultant Hepatologist at Imperial College Healthcare NHS Trust. He has lectured on liver disease nationally and internationally at Hepatology and Gastroenterology conferences, including state of the art and invited presentations. He is the lead author on the National guidelines for biliary cancer and is co-author on both the International and European guidelines. He has published extensively in the medical literature, including original research articles, reviews and book chapters. Professor Khan is currently Chair of Cholangiocarcinoma UK and serves on the NRCI HPB Cancer National Sub-group Committee and the Advisory Boards of the International Liver Cancer Association and the AMMF Cholangiocarcinoma UK Charity. Professor Khan enjoys a large teaching role, at both undergraduate and postgraduate level and is an accredited UK Royal College of Physicians Educator and. He has supervised several PhD/MD studies in liver disease and is also Director of Admissions and Inclusivity for Imperial College Medical School, as well as previously serving as Director of the Gastroenterology & Hepatology BSc degree programme at Imperial College London and Director of Clinical Studies at St Mary’s Hospital Campus. In light of his educational achievements, he has been selected as a Senior Fellow of the UK’s Higher Education Academy and has won Teaching awards at Imperial College London. He is a member of the British Medical Association, the Association of Physicians of GB and Ireland, the British Association for the Study of the Liver, the British Society of Gastroenterology, the European Association for the Study of the Liver and the International Liver Cancer Association, where he has served as the Chair of a Special Interest Group on biliary cancer.

Professor Emmanouil Tsochatzis

University College London Institute for Liver and Digestive Health, Royal Free Hospital

Speaker's biography

Professor Emmanouil Tsochatzis is a Professor of Hepatology and Consultant at the UCL Institute for Liver and Digestive Health in the Royal Free Hospital and Head of the Centre for Metabolic Liver Diseases in ILDH. He leads the specialist multidisciplinary service in NAFLD and has an active research program. His clinical and research interests include NAFLD, cirrhosis and portal hypertension, non-invasive fibrosis assessment, cirrhosis and portal hypertension and metabolic liver disease including Wilson’s disease and iron disorders. Professor Tsochatzis finished his specialty training and PhD in Hippokration General Hospital in Greece, before moving to the Royal Free Hospital for his post-doc research. He has been a consultant hepatologist and a clinical academic since 2014. Since 2019, he is a member of the Scientific Committee and Governing Board of EASL. He sits on national and international clinical guideline committees, serves as specialist advisor to NICE, and is actively involved in undergraduate and postgraduate education. He is a member of the steering committee of the Baveno collaboration for portal hypertension. He has led several international research collaborations resulting in more than 230 publications in peer reviewed journals. He has designed pathways for risk stratification of patients with liver disease in primary care and is passionate on improving the outcomes of patients with liver disease. He has received funding for his research from NIHR, EASL and EU Horizon 2020.

Agenda

View the programme here

Registration tea and coffee
Welcome and introduction

Session one: Acute liver injury

Drug induced liver injury and complications of immunotherapy

Dr Lucia Possamai, Consultant Hepatologist, Imperial College Healthcare NHS Trust

Acute liver failure

Dr Mark Mcphail, Consultant Hepatologist and Liver Intensive Care, Kings College Hospital

Panel discussion
Tea and coffee break

Session two: Lifestyle and liver

Update on alcohol related liver disease

Professor Mark Thursz, Head of Department: Metabolism Digestion and Reproduction, Imperial College London

Update on non-alcoholic fatty liver disease

Dr Jeremy Cobbold, Consultant Hepatologist, Oxford University Hospitals 

Panel discussion
Lunch break

Session three: Cirrhosis and its complications

Acute on chronic liver failure

Dr Brian Hogan, Consultant in Critical Care and Hepatology, Kings College Hospital

Splanchnic Vein Thrombosis: What should we be doing?

Dr David Patch, Consultant Hepatologist, Royal Free Hospital, London

Panel discussion
Tea and coffee break
Advances in portal hypertension

Professor Emmanouil Tsochatzis, Professor of Hepatology and Consultant Hepatologist, University College London Institute for Liver and Digestive Health, Royal Free Hospital

Update on the management of Hepatocellular Carcinoma

Professor Shahid Khan, Consultant Hepatologist, Imperial College London

Panel discussion
Closing remarks
Close of meeting

Sponsors

Location

Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom

Can't make it to London? Book the live stream here:

GSQ01 Promo
Live Stream

Live stream: Frontiers of liver disease: Managing the impact of advanced liver disease

This live stream is an opportunity for delegates to refresh their knowledge in the management of key hepatological topics. Talks will be delivered by leading experts in their field and there will be an emphasis on recent clinical advances in these areas to allow participants to be kept fully updated. Join this meeting to understand the advances in managing complications of liver disease and more.

Book Book

Disclaimer: All views expressed at this event are of the speakers themselves and not of the RSM nor the speaker's organisations.

Registration for this event will close at 01:00am on Sunday 31 October 2021Late registrations will not be accepted.

This event will be recorded and stored by the Royal Society of Medicine and may be  distributed  in future on various internet channels. 

Man searching computer

Join the RSM and get unlimited digital learning and e-resources access

The RSM has an extensive digital learning and online e-resources platform. As a member you'll enjoy unlimited digital learning any time you need and access to e-journals, e-books and 6 huge medical databases to support your clinical decision-making and research.

Our e-resources are updated continuously to ensure you receive the cutting edge knowledge you need. 

 

Become a member